Inventor
SMALLHEER JOANNE M
US34 patents
⚠️ This page may combine multiple inventors who share the name “SMALLHEER JOANNE M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
24 patentsUS7129264B2Oct 31, 2006
Biarylmethyl indolines and indoles as antithromboembolic agents
BRISTOL MYERS SQUIBB CO88 citations97
US7626039B2Dec 1, 2009
Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO14 citations92
US7459564B2Dec 2, 2008
Substituted biaryl compounds as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO26 citations92
US7453002B2Nov 18, 2008
Five-membered heterocycles useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO24 citations92
US7417063B2Aug 26, 2008
Bicyclic heterocycles useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO27 citations92
US7157470B2Jan 2, 2007
Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
BRISTOL MYERS SQUIBB CO24 citations92
US7429604B2Sep 30, 2008
Six-membered heterocycles useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO35 citations90
US10487086B2Nov 26, 2019
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US9802939B2Oct 31, 2017
Macrocycles as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US7645799B2Jan 12, 2010
Substituted biaryl compounds as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO7 citations74
US11136327B2Oct 5, 2021
Macrocycles as factor XIA inhibitors
BRISTOL MYERS SQUIBB CO1 citations73
US10214527B2Feb 26, 2019
Triazolopyridine inhibitors of myeloperoxidase
BRISTOL MYERS SQUIBB CO2 citations71
US12404274B2Sep 2, 2025
Macrocycles as factor xia inhibitors
BRISTOL MYERS SQUIBB CO0 citations62
US7842708B2Nov 30, 2010
Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors
BRISTOL MYERS SQUIBB CO4 citations62
US10407422B2Sep 10, 2019
Triazolopyridine inhibitors of myeloperoxidase
BRISTOL MYERS SQUIBB CO1 citations60
US10112936B2Oct 30, 2018
Five-membered heterocycles useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US9617224B2Apr 11, 2017
Five-membered heterocycles useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US9079860B2Jul 14, 2015
Five-membered heterocycles useful as serine protease inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US7524863B2Apr 28, 2009
Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US12577206B2Mar 17, 2026
Pyrazolone formyl peptide 2 receptor agonists
BRISTOL MYERS SQUIBB CO0 citations50
US11180490B2Nov 23, 2021
Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists
BRISTOL MYERS SQUIBB CO0 citations50
US11008317B2May 18, 2021
Triazolopyridine inhibitors of myeloperoxidase and/or EPX
BRISTOL MYERS SQUIBB CO0 citations49
US11059818B2Jul 13, 2021
Triazolopyridine inhibitors of myeloperoxidase
BRISTOL MYERS SQUIBB CO0 citations47
US10577383B2Mar 3, 2020
Macrocyclic inhibitors of myeloperoxidase
BRISTOL MYERS SQUIBB CO0 citations39
BRISTOL MYERS SQUIBB PHARMA CO
3 patentsUS6710058B2Mar 23, 2004
Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO28 citations92
US6951872B2Oct 4, 2005
Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
BRISTOL MYERS SQUIBB PHARMA CO14 citations83
US6476226B2Nov 5, 2002
Isoxazoline fibrinogen receptor antagonists
BRISTOL MYERS SQUIBB PHARMA CO1 citations51
HANGELAND JON J
2 patentsPINTO DONALD J P
2 patentsUS8604056B2Dec 10, 2013
Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors
PINTO DONALD J P0 citations51
US8252830B2Aug 28, 2012
Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors
PINTO DONALD J P0 citations51